Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kiniksa Pharmaceuticals International (KNSA) Cash from Financing Activities: 2017-2024

Historic Cash from Financing Activities for Kiniksa Pharmaceuticals International (KNSA) over the last 8 years, with Dec 2024 value amounting to $12.3 million.

  • Kiniksa Pharmaceuticals International's Cash from Financing Activities rose 77.89% to $11.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $27.5 million, marking a year-over-year increase of 154.25%. This contributed to the annual value of $12.3 million for FY2024, which is 720.47% up from last year.
  • Latest data reveals that Kiniksa Pharmaceuticals International reported Cash from Financing Activities of $12.3 million as of FY2024, which was up 720.47% from $1.5 million recorded in FY2023.
  • Over the past 5 years, Kiniksa Pharmaceuticals International's Cash from Financing Activities peaked at $227.1 million during FY2020, and registered a low of $1.5 million during FY2023.
  • For the 3-year period, Kiniksa Pharmaceuticals International's Cash from Financing Activities averaged around $5.4 million, with its median value being $2.5 million (2022).
  • Per our database at Business Quant, Kiniksa Pharmaceuticals International's Cash from Financing Activities crashed by 97.41% in 2021 and then skyrocketed by 720.47% in 2024.
  • Yearly analysis of 5 years shows Kiniksa Pharmaceuticals International's Cash from Financing Activities stood at $227.1 million in 2020, then crashed by 97.41% to $5.9 million in 2021, then slumped by 57.25% to $2.5 million in 2022, then slumped by 40.58% to $1.5 million in 2023, then surged by 720.47% to $12.3 million in 2024.